Epilepsy, anti-epileptic drugs and osteoporosis: prevalence of osteoporosis in adults with epilepsy. Epilepsie, anti-epileptica en botontkalking: een onderzoek naar hoe vaak botontkalking voorkomt onder volwassenen met epilepsie.

Epilepsy, anti-epileptic drugs and osteoporosis: prevalence of osteoporosis in adults with epilepsy, a retrospective study in Atrium Medical Centre Parkstad.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28623

Enrollment

Registered

2009-09-19

Start date

2010-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, osteoporosis, anti-epileptic drugs, bone metabolism. Epilepsie, osteoporose, anti-epileptica, botmetabolisme.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults >= 18 years; 2. Diagnosis of epilepsy; 3. Current treatment wit anti-epileptic drugs.

Exclusion criteria

Exclusion criteria: 1. No dual-energy X-ray absorptiometry; 2. No determination of calcium, 25-hydroxy vitamin D, alkaline phosphatase and parathormone.

Design outcomes

Primary

Measure	Time frame
T-score DEXA scan.	—

Secondary

Measure	Time frame
1. Association between bone mineral density and use of type of anti-epileptic drug(s); 2. Association between bone mineral density and number of anti-epileptic drugs and dosage.	—

Contacts

Public ContactK. Beerhorst

Henri Dunantstraat 5 Postbus 4446

K.Beerhorst@atriummc.nl+31 (0)45-5766700

Outcome results